Logo image of BZAI

BLAIZE HOLDINGS INC (BZAI) Stock Fundamental Analysis

NASDAQ:BZAI - Nasdaq - US0929151076 - Common Stock - Currency: USD

2.91  +0.1 (+3.56%)

After market: 2.8 -0.11 (-3.78%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to BZAI. BZAI was compared to 110 industry peers in the Semiconductors & Semiconductor Equipment industry. BZAI has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, BZAI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year BZAI has reported negative net income.
In the past year BZAI has reported a negative cash flow from operations.
BZAI had negative earnings in 4 of the past 5 years.
BZAI had negative operating cash flow in 4 of the past 5 years.
BZAI Yearly Net Income VS EBIT VS OCF VS FCFBZAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

BZAI has a worse Return On Assets (-212.02%) than 98.18% of its industry peers.
Industry RankSector Rank
ROA -212.02%
ROE N/A
ROIC N/A
ROA(3y)-181.79%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BZAI Yearly ROA, ROE, ROICBZAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -200 -400

1.3 Margins

BZAI's Gross Margin of 70.18% is amongst the best of the industry. BZAI outperforms 91.82% of its industry peers.
BZAI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 70.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BZAI Yearly Profit, Operating, Gross MarginsBZAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -1K -2K -3K

2

2. Health

2.1 Basic Checks

BZAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
BZAI has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for BZAI has been reduced compared to a year ago.
BZAI Yearly Shares OutstandingBZAI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M 100M
BZAI Yearly Total Debt VS Total AssetsBZAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

BZAI has an Altman-Z score of -7.38. This is a bad value and indicates that BZAI is not financially healthy and even has some risk of bankruptcy.
BZAI has a Altman-Z score of -7.38. This is amonst the worse of the industry: BZAI underperforms 80.91% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.38
ROIC/WACCN/A
WACC11.12%
BZAI Yearly LT Debt VS Equity VS FCFBZAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

A Current Ratio of 2.14 indicates that BZAI has no problem at all paying its short term obligations.
BZAI has a worse Current ratio (2.14) than 70.91% of its industry peers.
BZAI has a Quick Ratio of 1.93. This is a normal value and indicates that BZAI is financially healthy and should not expect problems in meeting its short term obligations.
BZAI has a Quick ratio of 1.93. This is comparable to the rest of the industry: BZAI outperforms 41.82% of its industry peers.
Industry RankSector Rank
Current Ratio 2.14
Quick Ratio 1.93
BZAI Yearly Current Assets VS Current LiabilitesBZAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 50M 100M 150M

4

3. Growth

3.1 Past

BZAI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1073.70%.
BZAI shows a strong growth in Revenue. In the last year, the Revenue has grown by 266.48%.
EPS 1Y (TTM)-1073.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-877.25%
Revenue 1Y (TTM)266.48%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%83.42%

3.2 Future

BZAI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.07% yearly.
The Revenue is expected to grow by 770.36% on average over the next years. This is a very strong growth
EPS Next Y-110.81%
EPS Next 2Y23.07%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1504.31%
Revenue Next 2Y770.36%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

BZAI Yearly Revenue VS EstimatesBZAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 20M 40M 60M 80M 100M
BZAI Yearly EPS VS EstimatesBZAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 -0.2 -0.4 -0.6 -0.8 -1

1

4. Valuation

4.1 Price/Earnings Ratio

BZAI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BZAI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BZAI Price Earnings VS Forward Price EarningsBZAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BZAI Per share dataBZAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5 -2

4.3 Compensation for Growth

BZAI's earnings are expected to grow with 23.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.07%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for BZAI!.
Industry RankSector Rank
Dividend Yield N/A

BLAIZE HOLDINGS INC

NASDAQ:BZAI (7/14/2025, 8:00:02 PM)

After market: 2.8 -0.11 (-3.78%)

2.91

+0.1 (+3.56%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)N/A N/A
Inst Owners40.98%
Inst Owner Change0%
Ins Owners11.2%
Ins Owner Change5.51%
Market Cap295.89M
Analysts80
Price Target5.95 (104.47%)
Short Float %1.78%
Short Ratio2.31
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-19.54%
PT rev (3m)N/A
EPS NQ rev (1m)7.41%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-63.82%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-0.24%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-9.85%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 147.06
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.05
EYN/A
EPS(NY)-0.29
Fwd EYN/A
FCF(TTM)-0.62
FCFYN/A
OCF(TTM)-0.61
OCFYN/A
SpS0.02
BVpS-1.05
TBVpS-1.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -212.02%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 70.18%
FCFM N/A
ROA(3y)-181.79%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 168.2%
Cap/Sales 68.89%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.14
Quick Ratio 1.93
Altman-Z -7.38
F-Score3
WACC11.12%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1073.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-877.25%
EPS Next Y-110.81%
EPS Next 2Y23.07%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)266.48%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%83.42%
Revenue Next Year1504.31%
Revenue Next 2Y770.36%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-516.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-4340.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4243.57%
OCF growth 3YN/A
OCF growth 5YN/A